Chronic Q fever endocarditis.
AUTOR(ES)
Varma, M P
RESUMO
Eight patients with chronic Q fever endocarditis were treated with tetracycline for up to 40 months. In addition, five of these patients received co-trimoxazole. Six patients had prosthetic valves. Two patients who had Q fever endocarditis on their native valves required valve replacement because of haemodynamic difficulties: in only one did the Q fever endocarditis contribute to the haemodynamic difficulty. One patient died. It is suggested that medical treatment is continued until clinically and haematologically there is no evidence of endocarditis and the Q fever phase 1 antibody titre is less than 200. No recurrence of Q fever endocarditis has been detected in three of our patients who have now stopped treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=482771Documentos Relacionados
- Q fever endocarditis.
- CD4+ T-cell lymphopenia in Q fever endocarditis.
- In vivo endogenous spore formation by Coxiella burnetii in Q fever endocarditis.
- Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis.
- Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.